Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.
Institute of Virology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
Science. 2023 Oct 6;382(6666):eadj0070. doi: 10.1126/science.adj0070.
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)-1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection.
在严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 大流行期间,多种逃避先前存在的免疫的变体出现,导致先前暴露的个体再次感染。在这里,我们使用抗原作图分析了 21 种变体和 15 组人类血清之间的交叉反应模式,这些血清是在感染 10 种不同变体或接种信使 RNA(mRNA)-1273 或 mRNA-1273.351 后获得的。我们发现,刺突蛋白位置 417、452、484 和 501 的取代导致了奥密克戎之前变体之间的抗原差异。通过定量分析随着时间的推移和随着额外剂量的疫苗接种,我们的结果表明,第二剂后 4 周和 >3 个月之间的反应广度增加最大。我们发现,不同刺突区域的免疫优势会发生变化,具体取决于个体首次接触的变体,这对变体风险评估和疫苗株选择有影响。